Clinical trials
Breast - Female clinical trials
Below are recruiting breast - female clinical trials, each written for real people, not researchers. We’re tracking 3,701 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT04982276RecruitingPhase 1/Phase 2
Test new cancer drugs for advanced stomach or esophagus cancer
This Phase 1/2 study tests the safety and effectiveness of two investigational drugs (AK109 and AK104) in people with advanced stomach (or lower esophagus/GEJ) cancer. It’s for cases where the cancer did not respond to first-line treatment that included anti–PD-1/PD-L1 therapy plus chemotherapy.
BeijingAges 18–75 - NCT06056583RecruitingPhase 4
How cimetidine passes into breast milk
This study looks at how the drug cimetidine gets into breast milk after healthy mothers take it. The goal is to find out how much reaches the baby and how it affects their body.
Seattle, WashingtonAges 2 weeks–50 years - NCT05800223RecruitingPhase 3
Armatinib with or without brain radiation for EGFR lung cancer
This study tests whether armatinib alone or combined with focused brain radiation (SRT) can control brain metastases from EGFR-mutated non-small cell lung cancer. It aims to improve outcomes for people with few, mostly low-symptom brain spots.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT07562321Recruiting
AI-Assisted Learning for Breast Self-Examination Training
This study tests a new way to teach nursing students about breast self-examination using artificial intelligence and flipped learning (where you study materials at home, then practice in class). The goal is to see if this method helps students learn better and feel more confident performing breast exams.
Ankara, AnkaraAges Any age - NCT07355972RecruitingEarly Phase 1
CT1195E cell therapy for progressive scleroderma
This trial tests a new cell therapy called CT1195E for people with refractory or progressive systemic sclerosis (scleroderma) that also affects the lungs. It aims to see if the treatment is safe and can help slow or stop the disease.
Wuhan, HubeiAges 18–60 - NCT05984810RecruitingPhase 2
Using a glowing dye to help see pancreatic cancer during surgery
This trial tests whether a special dye (SGM-101) can help surgeons see remaining cancer cells during surgery for pancreatic cancer that has been treated before surgery. It may lead to more complete removal of the tumor.
LeidenAges 18 years+ - NCT07071896Recruiting
Video exercise program for breast cancer survivors
This study tests a video-based exercise program for people who recently had breast cancer surgery. It aims to help with recovery by providing guided exercises you can do at home.
San Diego, CaliforniaAges 18 years+ - NCT06633250Recruiting
Testing a rice-based formula for babies with cow's milk allergy
This trial tests a special formula made from hydrolyzed rice protein in babies with cow's milk protein allergy. The goal is to see if the formula supports healthy growth and is well-tolerated, while also improving quality of life.
BerlinAges Up to 8 months - NCT07136285RecruitingPhase 1/Phase 2
Olvi-Vec plus chemotherapy for advanced small cell lung cancer
This trial tests a new drug called Olvi-Vec combined with standard chemotherapy (platinum plus etoposide) for people with advanced small cell lung cancer that has already been treated and is no longer responding. The goal is to see if this combination can help shrink tumors or slow the cancer.
HangzhouAges 18 years+ - NCT07537673RecruitingPhase 2
Ear Stimulation Plus Steroid for Chemo Nausea Relief
This trial tests whether stimulating specific points on your ear combined with a steroid medication can reduce nausea and vomiting caused by trastuzumab deruxtecan, a breast cancer drug. The goal is to help you feel better during treatment.
HangzhouAges 18–85 - NCT06751043Recruiting
Testing if fasting before a procedure is needed in ICU patients
This trial tests whether not eating before a procedure (called preoperative fasting) is better than fasting in ICU patients who are already receiving tube feedings. It aims to find out if skipping the fast can help you without causing extra risks.
Palo Alto, CaliforniaAges 18 years+ - NCT06990529RecruitingPhase 2
Long-term safety and effectiveness of leniolisib for immune problems
This study tests the long-term safety and effectiveness of the drug leniolisib for people with certain immune system disorders. It is for people who have already been in a previous study of this drug and may benefit from continuing treatment.
Bethesda, MarylandAges 12–75 - NCT07478341Recruiting
Breastfeeding education for first-time mothers in late pregnancy
This study tests a hybrid (online and in-person) breastfeeding education program for first-time mothers at 36 weeks or later. It aims to see if the program helps with bonding with the baby and successful breastfeeding.
Elbistan, KahramanmaraşAges 18–35 - NCT06436157Recruiting
Genetic testing support through a nurse-led program
This study tests whether a special program led by oncology nurses can help more people with solid tumor cancers get genetic testing. If you are starting a new treatment and have not had genetic testing before, this program may help you learn about your cancer risks and treatment options.
Chico, CaliforniaAges 18 years+ - NCT05761470RecruitingPhase 2
Test before-surgery cancer treatment for breast tumors with DNA repair gene changes
This trial tests a combination of medications given before surgery (neoadjuvant therapy) for early breast cancer. It is designed for tumors with certain “DNA repair” gene mutations and aims to improve treatment results while shrinking or controlling the cancer.
Guangzhou, GuangdongAges 18–75 - NCT06746168Recruiting
Better pain control after knee replacement surgery
This study tests a new way to manage pain after total knee replacement. It aims to see if a specific local pain block can reduce the need for strong opioids and improve recovery.
Hasselt, LimburgAges 18–85 - NCT07492160RecruitingPhase 2
Cabergoline for Breast Symptoms After Pregnancy Loss
This study tests whether a medication called cabergoline can help stop milk production and reduce breast discomfort after a pregnancy loss or abortion.
Brooklyn, New YorkAges 18 years+ - NCT05768464RecruitingPhase 2
Surgery aftercare for non-clear kidney cancer at high risk
This Phase 2 trial studies an after-surgery treatment for people with non-clear types of kidney cancer who are at high risk of coming back. It aims to lower the chance of recurrence by giving extra therapy after your tumor is completely removed.
Nanjing, JiangsuAges 18–75 - NCT06737809Recruiting
Silver-coated hip revision for infection
This trial tests a new silver-coated hip implant for people who need a revision due to a chronic infection around the joint. It may help control the infection while replacing the implant.
BerlinAges 18 years+ - NCT07706127Recruiting
Texting support for Latina breast cancer patients on hormone therapy
This study tests if a text message program can help Latina breast cancer patients remember to take their hormone therapy pills. It also looks at how non-medical challenges (like money or housing issues) affect medication taking.
San Antonio, TexasAges 18 years+ - NCT06762977Recruiting
Study on her2-positive early-stage breast cancer treatment
This study looks at how well a new test can help manage her2-positive early-stage breast cancer. It includes patients who have had treatment before or after surgery with trastuzumab and possibly pertuzumab.
BrindisiAges 18 years+ - NCT07269145RecruitingPhase 1
Testing TQB3122 capsules in advanced solid tumors
This trial tests an experimental oral capsule (TQB3122) for safety and early signs of effectiveness in people with advanced solid tumors that have not responded to standard therapies. It is for patients who are relatively healthy and have specific cancer types like ovarian, breast, or prostate cancer.
Beijing, Beijing MunicipalityAges 18–75 - NCT06508710RecruitingPhase 3
Ketamine plus venlafaxine for severe depression
This trial tests whether adding ketamine to the antidepressant venlafaxine helps relieve severe depression faster than venlafaxine alone. If you are hospitalized for a serious depression and you meet safety criteria, you may be eligible.
Le Kremlin-Bicêtre, FranceAges 18–65 - NCT07180264Recruiting
Trastuzumab deruxtecan for advanced breast cancer
This trial tests a targeted therapy called trastuzumab deruxtecan for people with advanced breast cancer. It aims to see how well the treatment works and how safe it is.
ShanghaiAges 18 years+
Hear when a new Breast - Female trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for breast - female?
- Yes. Clin2 currently lists 3,701 recruiting breast - female studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a breast - female trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a breast - female trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.